We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-4.51%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$481M
AUM Growth
-$36.5M
Cap. Flow
-$7.21M
Cap. Flow %
-1.5%
Top 10 Hldgs %
70.42%
Holding
77
New
4
Increased
18
Reduced
37
Closed
9

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$9.69M
2
VTRS icon
Viatris
VTRS
+$3.15M
3
OGN icon
Organon & Co
OGN
+$2.13M
4
MO icon
Altria Group
MO
+$1.72M
5
OXY icon
Occidental Petroleum
OXY
+$1.59M

Sector Composition

Rank Sector Weight
1 Financials 37.1%
2 Energy 17.13%
3 Healthcare 16.46%
4 Technology 11.68%
5 Consumer Staples 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$164M 34.09%
613,981
-1,577
-0.3% -$449K
XOM icon
2
ExxonMobil
XOM
$658B
$54.6M 11.36%
625,686
-4,795
-0.8% -$438K
OXY.WS icon
3
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$21.8M 4.53%
549,893
+23,831
+5% +$1M
QCOM icon
4
Qualcomm
QCOM
$172B
$18.6M 3.86%
164,328
-649
-0.4% -$89.2K
INTC icon
5
Intel
INTC
$460B
$16.2M 3.36%
627,683
+284,197
+83% +$9.69M
KHC icon
6
Kraft Heinz
KHC
$29.2B
$13.9M 2.88%
415,388
-96,459
-19% -$3.58M
JNJ icon
7
Johnson & Johnson
JNJ
$652B
$13.5M 2.81%
82,583
-1,615
-2% -$273K
IBM icon
8
IBM
IBM
$217B
$12.8M 2.65%
107,476
-9,595
-8% -$1.26M
BABA icon
9
Alibaba
BABA
$288B
$11.8M 2.45%
147,023
+2,541
+2% +$242K
GILD icon
10
Gilead Sciences
GILD
$184B
$11.7M 2.43%
189,734
-63,422
-25% -$4M
CAH icon
11
Cardinal Health
CAH
$55.2B
$10M 2.09%
150,591
-52,449
-26% -$3.32M
COP icon
12
ConocoPhillips
COP
$159B
$9.57M 1.99%
93,535
-6,200
-6% -$618K
OGN icon
13
Organon & Co
OGN
$3.61B
$9.07M 1.89%
387,520
+70,396
+22% +$2.13M
AMGN icon
14
Amgen
AMGN
$239B
$8.72M 1.81%
38,708
-1,387
-3% -$336K
OXY icon
15
Occidental Petroleum
OXY
$58.7B
$8.09M 1.68%
131,722
+24,865
+23% +$1.59M
BAC icon
16
Bank of America
BAC
$436B
$7.91M 1.64%
261,760
-5,245
-2% -$175K
VTRS icon
17
Viatris
VTRS
$19.3B
$7.17M 1.49%
841,787
+320,394
+61% +$3.15M
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
$6.23M 1.3%
198,469
-115,735
-37% -$4.29M
KO icon
19
Coca-Cola
KO
$390B
$5.79M 1.2%
103,444
-14,899
-13% -$926K
MO icon
20
Altria Group
MO
$115B
$5.7M 1.18%
141,140
+39,527
+39% +$1.72M
CVX icon
21
Chevron
CVX
$395B
$5.39M 1.12%
37,487
+75
+0.2% +$11.4K
LLY icon
22
Eli Lilly
LLY
$1.06T
$4.73M 0.98%
14,625
-2,315
-14% -$733K
HD icon
23
Home Depot
HD
$336B
$4.12M 0.86%
14,932
-105
-0.7% -$31K
MRK icon
24
Merck
MRK
$378B
$4.04M 0.84%
46,945
-145
-0.3% -$12.9K
FDX icon
25
FedEx
FDX
$80.3B
$3.92M 0.81%
26,383
+630
+2% +$133K

Similar funds

Greylin Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Greylin Investment Management held 77 positions worth $481M, down 7.1% from $518M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Greylin Investment Management's Q3 2022 filing shows 4 new, 18 increased, 37 reduced and 9 closed positions. Its largest new stake was Ally Financial: 25,555 shares worth $711K. The largest sale was Walgreens Boots Alliance, an estimated $4.29M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q3 2022 buy was Ally Financial: 25,555 shares worth $711K.
  • Greylin Investment Management added most to Intel in Q3 2022, an estimated $9.69M increase.
  • Greylin Investment Management's biggest Q3 2022 reduction was Walgreens Boots Alliance, cutting an estimated $4.29M.
  • Greylin Investment Management fully exited GSK in Q3 2022, selling an estimated $1.66M.
  • Greylin Investment Management's ten largest holdings make up 70% of its $481M portfolio in Q3 2022.
  • Greylin Investment Management opened 4 new positions and closed 9 in Q3 2022.
  • Greylin Investment Management's portfolio value fell 7.1% quarter-over-quarter to $481M.

Based on Greylin Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.